Unspecified Adult Solid Tumor, Protocol Specific Clinical Trials Database - Free Access to 355 Studies
Access comprehensive clinical trial information for Unspecified Adult Solid Tumor, Protocol Specific through Pure Global AI's free database. This collection includes 355 clinical trials across multiple phases including Phase 1, N/A, Early Phase 1. Currently, 4 trials are actively recruiting participants.
Research for Unspecified Adult Solid Tumor, Protocol Specific is being conducted in United States of America, United Kingdom, Canada and 7+ other countries. Leading sponsors include National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors
TR1801-ADC in Patients With Tumors That Express c-Met
Communication Training in Promoting Employment Retention Among Cancer Patients
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Copenhagen Prospective Personalized Oncology (CoPPO)
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Icotinib Hydrochloride in Treating Patients With Advanced Cancers
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials
Pure Global AI provides free access to 355 clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, City of Hope Medical Center, among others.